{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:35:16Z","timestamp":1782236116881,"version":"3.54.5"},"reference-count":87,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ccm.2023.06.005","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T16:04:31Z","timestamp":1689696271000},"page":"15-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnosis of Pulmonary Sarcoidosis"],"prefix":"10.1016","volume":"45","author":[{"given":"Mengmeng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ccm.2023.06.005_bib1","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American thoracic society\/European respiratory society\/world association of sarcoidosis and other granulomatous disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ccm.2023.06.005_bib2","doi-asserted-by":"crossref","first-page":"106564","DOI":"10.1016\/j.rmed.2021.106564","article-title":"The impact of demographic disparities in the presentation of sarcoidosis: a multicenter prospective study","volume":"187","author":"Zhou","year":"2021","journal-title":"Respir Med"},{"issue":"5261","key":"10.1016\/j.ccm.2023.06.005_bib3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation","volume":"2","author":"SCADDING","year":"1961","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib4","first-page":"29","article-title":"Sarcoidosis: epidemiology and prognosis. A 15-year European study","volume":"130","author":"Hillerdal","year":"1984","journal-title":"Am Rev Respir Dis"},{"issue":"208","key":"10.1016\/j.ccm.2023.06.005_bib5","first-page":"525","article-title":"Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients","volume":"52","author":"Neville","year":"1983","journal-title":"Q\u00a0J Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.005_bib6","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis: comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.ccm.2023.06.005_bib7","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1007\/s00330-003-1965-x","article-title":"Sarcoidosis: assessment of disease severity using HRCT","volume":"13","author":"Drent","year":"2003","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12016-015-8478-7","article-title":"Imaging of sarcoidosis","volume":"49","author":"Silva","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.005_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00005382-199904000-00009","article-title":"Distribution of thoracic lymphadenopathy in sarcoidosis using computed tomography","volume":"14","author":"Patil","year":"1999","journal-title":"J\u00a0Thorac Imaging"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.005_bib10","first-page":"C15","article-title":"Thoracic sarcoidosis: imaging with high resolution computed tomography","volume":"11","author":"Dhagat","year":"2017","journal-title":"J\u00a0Clin Diagn Res"},{"issue":"8","key":"10.1016\/j.ccm.2023.06.005_bib11","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. an official american thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.005_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ccm.2015.08.004","article-title":"Chest imaging","volume":"36","author":"Keijsers","year":"2015","journal-title":"Clin Chest Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2049-6958-8-8","article-title":"HRCT findings of pulmonary sarcoidosis; relation to pulmonary function tests","volume":"8","author":"Ors","year":"2013","journal-title":"Multidiscip Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/thoraxjnl-2019-214348","article-title":"BTS clinical statement on pulmonary sarcoidosis","volume":"76","author":"Thillai","year":"2021","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.005_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11547-017-0830-y","article-title":"Atypical HRCT manifestations of pulmonary sarcoidosis","volume":"123","author":"Cozzi","year":"2018","journal-title":"Radiol Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.005_bib16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0037-1603765","article-title":"Imaging for sarcoidosis","volume":"38","author":"Calandriello","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2023.06.005_bib17","doi-asserted-by":"crossref","first-page":"106723","DOI":"10.1016\/j.rmed.2021.106723","article-title":"Sarcoidosis associated pleural effusion: clinical aspects","volume":"191","author":"Chopra","year":"2022","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/jcm9010142","article-title":"Computed tomography images of fibrotic pulmonary sarcoidosis leading to chronic respiratory failure","volume":"9","author":"Sawahata","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ccm.2023.06.005_bib19","doi-asserted-by":"crossref","first-page":"106059","DOI":"10.1016\/j.rmed.2020.106059","article-title":"Chest CT scan: the best predictor of mortality in advanced pulmonary sarcoidosis?","volume":"170","author":"Kirkil","year":"2020","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.ccm.2023.06.005_bib20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/thoraxjnl-2016-208833","article-title":"CTAS: a CT score to quantify disease activity in pulmonary sarcoidosis","volume":"71","author":"Benamore","year":"2016","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.ccm.2023.06.005_bib21","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2022.1570","article-title":"Diagnosis and treatment of pulmonary sarcoidosis: a review","volume":"327","author":"Belperio","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis","volume":"153","author":"Kirkil","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.06.005_bib23","doi-asserted-by":"crossref","first-page":"105997","DOI":"10.1016\/j.rmed.2020.105997","article-title":"Predictors of mortality in fibrosing pulmonary sarcoidosis","volume":"169","author":"Jeny","year":"2020","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.005_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.005_bib25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1183\/13993003.01319-2015","article-title":"Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis","volume":"47","author":"Huitema","year":"2016","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.005_bib26","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1378\/chest.07-1178","article-title":"Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis","volume":"132","author":"Teirstein","year":"2007","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.005_bib27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4081\/monaldi.2020.1456","article-title":"Predictors of mortality in hospitalized patients with influenza: a five-year experience from a tertiary care centre in Pakistan","volume":"90","author":"Khanum","year":"2020","journal-title":"Monaldi Arch Chest Dis"},{"issue":"8","key":"10.1016\/j.ccm.2023.06.005_bib28","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00259-008-0770-9","article-title":"18F-FDG PET\/CT in sarcoidosis management: review and report of 20 cases","volume":"35","author":"Braun","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.005_bib29","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1378\/chest.06-2160","article-title":"Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients","volume":"131","author":"Kaira","year":"2007","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.005_bib30","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00259-009-1097-x","article-title":"18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis","volume":"36","author":"Keijsers","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.005_bib31","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1378\/chest.14-1827","article-title":"Dual-time point whole-body 18F-fluorodeoxyglucose PET\/CT imaging in undiagnosed mediastinal lymphadenopathy: a prospective study of 117 patients with sarcoidosis and TB","volume":"146","author":"Maturu","year":"2014","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.ccm.2023.06.005_bib32","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.amjcard.2015.08.025","article-title":"F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis","volume":"116","author":"Simonen","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccm.2023.06.005_bib33","first-page":"1823710","article-title":"The utility of (18)F-FDG PET\/CT for monitoring response and predicting prognosis after glucocorticoids therapy for sarcoidosis","volume":"2018","author":"Chen","year":"2018","journal-title":"BioMed Res Int"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.005_bib34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1631\/jzus.2007.B0410","article-title":"Experiences and benefits of positron emitted tomography-computed tomography (PET-CT) combined with video-assisted thoracoscopic surgery (VATS) in the diagnosis of Stage 1 sarcoidosis","volume":"8","author":"Luh","year":"2007","journal-title":"J\u00a0Zhejiang Univ - Sci B"},{"issue":"11","key":"10.1016\/j.ccm.2023.06.005_bib35","first-page":"1943","article-title":"18F-FDG PET successfully detects spinal cord sarcoidosis","volume":"256","author":"Ota","year":"2009","journal-title":"J\u00a0Neurol"},{"issue":"9","key":"10.1016\/j.ccm.2023.06.005_bib36","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3346\/jkms.2013.28.9.1399","article-title":"Muscular sarcoidosis detected by F-18 FDG PET\/CT in a hypercalcemic patient","volume":"28","author":"Han","year":"2013","journal-title":"J\u00a0Korean Med Sci"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000204901","article-title":"Fluorine-18 fluorodeoxyglucose with positron emission tomography revealed bone marrow involvement in sarcoidosis patients with anaemia","volume":"79","author":"de Prost","year":"2010","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13550-019-0505-x","article-title":"Quantification of pulmonary disease activity in sarcoidosis measured with (18)F-FDG PET\/CT: SUVmax versus total lung glycolysis","volume":"9","author":"Schimmelpennink","year":"2019","journal-title":"EJNMMI Res"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.005_bib39","first-page":"123","article-title":"18F-FDG PET as a predictor of pulmonary function in sarcoidosis","volume":"28","author":"Keijsers","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.005_bib40","first-page":"372","article-title":"Role of serial F-18 FDG PET\/CT scans in assessing treatment response and predicting relapses in patients with symptomatic sarcoidosis","volume":"33","author":"Maturu","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.005_bib41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00408-017-9994-4","article-title":"Repository corticotropin for chronic pulmonary sarcoidosis","volume":"195","author":"Baughman","year":"2017","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.005_bib42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.005_bib44","doi-asserted-by":"crossref","first-page":"e13722","DOI":"10.1111\/eci.13722","article-title":"Identification and characterization of cardiac sarcoidosis with positron emission tomography","volume":"52","author":"Schindler","year":"2022","journal-title":"Eur J Clin Invest"},{"issue":"16","key":"10.1016\/j.ccm.2023.06.005_bib45","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.jacc.2020.08.042","article-title":"Challenges in cardiac and pulmonary sarcoidosis: JACC state-of-the-art Review","volume":"76","author":"Trivieri","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.005_bib46","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.005_bib47","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1034\/j.1399-3003.1999.13d04.x","article-title":"The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients","volume":"13","author":"Pietinalho","year":"1999","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1164\/ajrccm.156.1.9612011","article-title":"Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis","volume":"156","author":"Tomita","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.ccm.2023.06.005_bib49","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/thx.51.8.777","article-title":"Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis","volume":"51","author":"Furuya","year":"1996","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.005_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0009-9120(87)80123-6","article-title":"Diagnostic aspects of angiotensin converting enzyme in pulmonary sarcoidosis","volume":"20","author":"Bunting","year":"1987","journal-title":"Clin Biochem"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.005_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1445-5994.1999.tb00713.x","article-title":"Influence of angiotensin converting enzyme (ACE) genotype on interpretation of diagnostic tests for serum ACE activity","volume":"29","author":"Stokes","year":"1999","journal-title":"Aust N Z J Med"},{"issue":"9","key":"10.1016\/j.ccm.2023.06.005_bib52","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1373\/49.9.1510","article-title":"Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis","volume":"49","author":"Rothkrantz-Kos","year":"2003","journal-title":"Clin Chem"},{"issue":"8","key":"10.1016\/j.ccm.2023.06.005_bib53","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.rmed.2007.03.002","article-title":"Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum","volume":"101","author":"Bons","year":"2007","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00408-015-9826-3","article-title":"Diagnostic utility of angiotensin-converting enzyme in sarcoidosis: a population-based study","volume":"194","author":"Ungprasert","year":"2016","journal-title":"Lung"},{"key":"10.1016\/j.ccm.2023.06.005_bib55","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ajo.2018.07.010","article-title":"Serum angiotensin-converting enzyme has a high negative predictive value in the investigation for systemic sarcoidosis","volume":"194","author":"Niederer","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.005_bib56","first-page":"507","article-title":"Reconsideration of the cut-off value of angiotensin-converting enzyme for screening of sarcoidosis in Japanese patients","volume":"74","author":"Baba","year":"2019","journal-title":"J\u00a0Cardiol"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.005_bib57","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/17476348.2020.1751614","article-title":"Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis","volume":"14","author":"Schimmelpennink","year":"2020","journal-title":"Expet Rev Respir Med"},{"key":"10.1016\/j.ccm.2023.06.005_bib58","first-page":"4657502","article-title":"Diagnostic and staging value of serum angiotensin-converting enzyme in sarcoidosis","volume":"2022","author":"Wang","year":"2022","journal-title":"Comput Math Methods Med"},{"issue":"8","key":"10.1016\/j.ccm.2023.06.005_bib59","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJM198108203050804","article-title":"Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity","volume":"305","author":"Hunninghake","year":"1981","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.005_bib60","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","article-title":"Soluble interleukin 2 receptors are released from activated human lymphoid cells in\u00a0vitro","volume":"135","author":"Rubin","year":"1985","journal-title":"J\u00a0Immunol"},{"issue":"11","key":"10.1016\/j.ccm.2023.06.005_bib61","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/1744666X.2016.1196135","article-title":"Biomarkers in sarcoidosis","volume":"12","author":"Chopra","year":"2016","journal-title":"Expet Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib62","doi-asserted-by":"crossref","first-page":"e147258","DOI":"10.1371\/journal.pone.0147258","article-title":"Interleukin-2 receptor and angiotensin-converting enzyme as markers for ocular sarcoidosis","volume":"11","author":"Gundlach","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ccm.2023.06.005_bib63","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jamaophthalmol.2017.4771","article-title":"Diagnostic value of serum-soluble interleukin 2 receptor levels vs angiotensin-converting enzyme in patients with sarcoidosis-associated uveitis","volume":"135","author":"Groen-Hakan","year":"2017","journal-title":"Jama Ophthalmol"},{"issue":"10","key":"10.1016\/j.ccm.2023.06.005_bib64","doi-asserted-by":"crossref","first-page":"e223897","DOI":"10.1371\/journal.pone.0223897","article-title":"Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis","volume":"14","author":"Eurelings","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ccm.2023.06.005_bib65","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ebiom.2016.04.024","article-title":"Diagnostic performance of bronchoalveolar lavage fluid CD4\/CD8 ratio for sarcoidosis: a meta-analysis","volume":"8","author":"Shen","year":"2016","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.005_bib66","first-page":"305","article-title":"Comparison of the diagnostic value of different lymphocyte subpopulations in bronchoalveolar lavage fluid in patients with biopsy proven sarcoidosis","volume":"32","author":"Tanriverdi","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib67","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"12","key":"10.1016\/j.ccm.2023.06.005_bib68","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1183\/09031936.97.10122716","article-title":"The CD4\/CD8 ratio in BAL fluid is highly variable in sarcoidosis","volume":"10","author":"Kantrow","year":"1997","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1378\/chest.113.1.147","article-title":"Mediastinoscopy in patients with presumptive stage I sarcoidosis: a risk\/benefit, cost\/benefit analysis","volume":"113","author":"Reich","year":"1998","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.005_bib70","first-page":"93","article-title":"Differentiation of sarcoidosis from tuberculosis using real-time PCR assay for the detection and quantification of Mycobacterium tuberculosis","volume":"25","author":"Zhou","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.005_bib71","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1378\/chest.13-2339","article-title":"Endobronchial ultrasound-guided transbronchial needle aspiration vs conventional transbronchial needle aspiration in the diagnosis of sarcoidosis","volume":"146","author":"Gupta","year":"2014","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib72","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/LBR.0000000000000339","article-title":"Conventional transbronchial needle aspiration versus endobronchial ultrasound-guided transbronchial needle aspiration, with or without rapid on-site evaluation, for the diagnosis of sarcoidosis: a randomized controlled trial","volume":"24","author":"Madan","year":"2017","journal-title":"J\u00a0Bronchology Interv Pulmonol"},{"issue":"23","key":"10.1016\/j.ccm.2023.06.005_bib73","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.2013.5823","article-title":"Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial","volume":"309","author":"von Bartheld","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.005_bib74","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1164\/rccm.201504-0711OC","article-title":"Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis","volume":"193","author":"Tomassetti","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.005_bib75","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.chest.2018.05.003","article-title":"Sarcoidosis diagnostic score: a systematic evaluation to enhance the diagnosis of sarcoidosis","volume":"154","author":"Bickett","year":"2018","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.005_bib76","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1513\/AnnalsATS.202206-529OC","article-title":"Validation of the Sarcoidosis Diagnostic Score in a Multicontinental Study","volume":"20","author":"Jeny","year":"2023","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.005_bib77","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12016-015-8492-9","article-title":"Treatment of sarcoidosis","volume":"49","author":"Baughman","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.005_bib78","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1183\/09031936.05.00083404","article-title":"Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics","volume":"25","author":"Shorr","year":"2005","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.005_bib79","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1378\/chest.128.3.1483","article-title":"Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension","volume":"128","author":"Sulica","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.06.005_bib80","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.rmed.2018.04.015","article-title":"Clinical features of sarcoidosis associated pulmonary hypertension: results of a multi-national registry","volume":"139","author":"Baughman","year":"2018","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.005_bib81","doi-asserted-by":"crossref","first-page":"1700465","DOI":"10.1183\/13993003.00465-2017","article-title":"Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension","volume":"50","author":"Boucly","year":"2017","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.005_bib82","doi-asserted-by":"crossref","first-page":"1901747","DOI":"10.1183\/13993003.01747-2019","article-title":"Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry","volume":"55","author":"Shlobin","year":"2020","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.005_bib83","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1055\/s-0037-1603767","article-title":"Sarcoidosis-associated pulmonary hypertension","volume":"38","author":"Shlobin","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.005_bib84","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1378\/chest.09-2002","article-title":"Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation","volume":"138","author":"Baughman","year":"2010","journal-title":"Chest"},{"issue":"163","key":"10.1016\/j.ccm.2023.06.005_bib85","doi-asserted-by":"crossref","first-page":"210165","DOI":"10.1183\/16000617.0165-2021","article-title":"WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension","volume":"31","author":"Savale","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.005_bib86","first-page":"1855","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. The joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS)","volume":"46","author":"Galie","year":"2015","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.005_bib87","first-page":"e2021032","article-title":"Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study","volume":"38","author":"Huitema","year":"2022","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:18:00Z","timestamp":1759454280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523123000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0272523123000461"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2023.06.005","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis of Pulmonary Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2023.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}